IVVD News & Events

The major averages closed higher despite the price of oil having gained roughly 5% as investors continue to monitor developments in the Middle East. While the U.S. and Iran ceasefire deal remains intact, cracks have emerged as ongoing military activity in Lebanon, disputes over compliance, and continued restrictions in the Strait of Hormuz are all raising doubts.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Meta Platformsand CoreWeaveannounced aAres ManagementWhitestone REITfor $1.7BConstellation Brandsreportedand provided its outlook for FY27Disneyis planning to make "sizable" layoffs for up to 1,000 positions,Amazonadvanced after awas seen as validating the company's potential with AI2. WALL STREET CALLS:Texas Instrumentsto Buy at StifelDatadogto Buy at GuggenheimInstacartto Outperform at Raymond JamesCircle Internetto Sell at Compass PointZscalerto Neutral at BTIG3. AROUND THE WEB:The U.S. Department of Justice has opened an investigation into the National Football League over alleged anticompetitive tactics, WSJ saysTeslahas contacted suppliers recently to discuss the details on developing a smaller, cheaper electric SUV, Reuters reportsRene Haas, CEO of chip designer Arm, is in line to lead much of the international business of parent company SoftBank, while retaining his current position at Arm, The Financial Times saysAI cloud company Nebiusis in talks to acquire Israeli AI company AI21 Labs after Nvidiapulled out of negotiations with the firm, The Information reportsSamsungis planning to invest $4B to construct a chip packaging plant in northern Vietnam as the company expands it footprint in the country, Bloomberg reports4. MOVERS:Staar Surgicalwas higher after Canaccord upgraded the stock to BuyInvivydincreased after announcing the discovery and advancement of a measles antibody candidate while also providing an update on itsAehr Test Systemsgained after entering into aStubHubwas lower after the company agreed to pay $10M to settleApplied Digitalfell after5. EARNINGS/GUIDANCE:Beyond MeatreportedSimply Good Foodsand provided guidance for Q3 and FY26BlackBerry, with EPS and revenue beating consensusOrthofixreportedand reaffirmed its guidance for FY26Neogenand raised its guidance for FY26INDEXES:The Dow rose 275.88, or 0.58%, to 48,185.80, the Nasdaq gained 187.42, or 0.83%, to 22,822.42, and the S&P 500 advanced 41.85, or 0.62%, to 6,824.66.

The major averages were higher near noon despite the price of oil having jumped back above the $100 per barrel mark as investors continue to monitor developments in the Middle East after the U.S. and Iran agreed to a two-week ceasefire. While the ceasefire remains intact on paper, cracks have emerged as ongoing military activity in Lebanon, disputes over compliance, and continued restrictions in the Strait of Hormuz are all raising doubts.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Meta Platformsand CoreWeaveannounced aAres ManagementWhitestone REITfor $1.7BConstellation Brandsreported uand provided its outlook for FY27Disneyis planning to make "sizable" layoffs for up to 1,000 positions,The U.S. Department of Justice has opened an investigation into the National Football League over alleged anticompetitive tactics,2. WALL STREET CALLS:Texas Instrumentsto Buy at StifelDatadogto Buy at GuggenheimInstacartto Outperform at Raymond JamesCircle Internetto Sell at Compass PointZscalerto Neutral at BTIG3. AROUND THE WEB:Teslahas contacted suppliers recently to discuss the details on developing a smaller, cheaper electric SUV, Reuters reportsRene Haas, CEO of chip designer Arm, is in line to lead much of the international business of parent company SoftBank, while retaining his current position at Arm, The Financial Times saysAI cloud company Nebiusis in talks to acquire Israeli AI company AI21 Labs after Nvidiapulled out of negotiations with the firm, The Information reportsSamsungis planning to invest $4B to construct a chip packaging plant in northern Vietnam as the company expands it footprint in the country, Bloomberg reportsNissanwill deliver roughly 1,400 vehicles that were originally meant for the Middle East to the U.S. amid disruptions to its export plans caused by the Iran war, Nikkei Asia reports4. MOVERS:Staar Surgicalhigher after Canaccordthe stock to BuyInvivydincreases after announcing theof a measles antibody candidate while also providing an update on its Phase 3 DECLARATION study of VYD2311Aehr Test Systemsgains after entering into aSpire Globallower afterat $14Applied Digitalfalls after5. EARNINGS/GUIDANCE:Beyond MeatSimply Good Foodsand provided guidance for Q3 and FY26BlackBerrywith EPS and revenue beating consensusOrthofixand reaffirmed its guidance for FY26Neogenand raised its guidance for FY26INDEXES:Near midday, the Dow was up/down xxx%, or xxx, to xxx, the Nasdaq was up/down xxx%, or xxx, to xxx, and the S&P 500 was up/down xxx%, or xxx, to xxx.

Invivyd announced progress in its REVOLUTION clinical program for VYD2311, an investigational candidate for the prevention of symptomatic COVID-19. The company conducted a pre-specified sample size re-estimation analysis for its Phase 3 DECLARATION study, which triggered an upsizing of approximately 500 additional subjects. Invivyd noted that top-line results are now expected to shift modestly to the third quarter of 2026. Additionally, the company has aligned with the FDA on an initial Pediatric Study Plan, the "DRUMMER" study, to support a potential BLA for VYD2311 in children aged 0-11 years, contingent on the success of the DECLARATION study. "We are thrilled with our progress in the DECLARATION study. Pooled, blinded COVID-19 event accumulation is already robust, and our conservative upsizing algorithm means that we can move to higher confidence in statistical power with very modest additional time. This re-sizing was designed prospectively with our rapid recruitment speed in mind and our desire for the most robust potential dataset. We have an extraordinary, high-value opportunity to change infectious disease medicine near-term," said Marc Elia, chairman of Invivyd.